A structured, evidence-based risk management program developed through expert consensus was associated with lower refeeding ...

Bolt Biotherapeutics has acquired Prana Therapies in a stock-for-stock reverse merger and secured a concurrent $120 million private placement to advance Prana’s pipeline of next-generation ...

At OCP 2026 in San Jose, Nvidia opened Vera Rubin rack designs, AMD unveiled Helion and Intel detailed its GPU D-Series. No ...

North Dakota high school gymnasts and their coaches enter the 2026-2027 competitive season in mid-November with more uncertainty than ever. It will be the third season since their sport was labeled in ...

Starfighters Space plans a December captive-carry flight for STARLAUNCH 1 aboard an F-104, advancing its suborbital air-launch program.

Korea Communications Agency launches K-radio platform to revive data-driven ads Prototype debuts Nov. 11 with five major ...

South Korea's regulators will study letting crypto exchanges join the STO market. Tencent's WorkBuddy adopts Moonshot AI's ...

Explore the JioHotstar business model, revenue streams, subscription plans, advertising strategy and how the merger is reshaping India's streaming market.

Landmark results from the DeLLphi-305 Phase III trial showed IMFINZI® (durvalumab) plus Amgen’s tarlatamab-dlle demonstrated a statistically significant and highly clinically meaningful improvement in ...

Positive results from the VOLGA Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with neoadjuvant enfortumab vedotin (EV) demonstrated ...